The Centers for Disease Control and Prevention Friday updated its April testing guidance for clinicians treating children with hepatitis of unknown cause. The agency is investigating 109 potential hepatitis cases of unknown cause in U.S. children since last October, including five deaths. More than 90% of the patients were hospitalized, 14% received liver transplants and more than half had a confirmed adenovirus infection, but officials still don’t know the actual cause of their hepatitis and cautioned that it may take time to assess the evidence and learn more. Potential cases also have been reported in the United Kingdom and other countries. 

Related News Articles

Headline
The Administration for Strategic Preparedness and Response is seeking public feedback on its Hospital Preparedness Program funding formula. The HPP is the…
Headline
In this AHA blog Aisha Syeda, senior program manager for AHA’s Strategic Initiatives, summarizes five action steps hospitals can take to establish pediatric…
Blog
In 2024, the U.S. suffered 24 weather and climate disasters. In October alone, two major hurricanes devastated communities in North Carolina and Florida,…
Headline
The California Department of Public Health Saturday reported the first known case of clade I mpox in the U.S. to the Centers for Disease Control and Prevention…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued…